Italian biotech Cassiopea has won US approval for Winlevi, a topical therapy it says is the first new approach to treating acne in nearly 40 years. An androgen receptor inhibitor, Winlevi ...
In August 2020, Cassiopea received US Food and Drug Administration (FDA) approval for its first-in-class acne topical treatment Winlevi (clascoterone) cream 1%, and it currently has three other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback